Related references
Note: Only part of the references are listed.Epigenetic Reader Bromodomain Containing Protein 2 Facilitates Pathological Cardiac Hypertrophy via Regulating the Expression of Citrate Cycle Genes
Zhirong Lin et al.
FRONTIERS IN PHARMACOLOGY (2022)
FAM114A1 influences cardiac pathological remodeling by regulating angiotensin II signaling
Kadiam C. Venkata Subbaiah et al.
JCI INSIGHT (2022)
MicroRNA-574 regulates FAM210A expression and influences pathological cardiac remodeling
Jiangbin Wu et al.
EMBO MOLECULAR MEDICINE (2021)
Diffuse myocardial fibrosis: mechanisms, diagnosis and therapeutic approaches
Begona Lopez et al.
NATURE REVIEWS CARDIOLOGY (2021)
Celecoxib alleviates pathological cardiac hypertrophy and fibrosis via M1-like macrophage infiltration in neonatal mice
Yanli Zhao et al.
ISCIENCE (2021)
Cardiac fibrosis: Myofibroblast-mediated pathological regulation and drug delivery strategies
Mengrui Liu et al.
ADVANCED DRUG DELIVERY REVIEWS (2021)
The BET family in immunity and disease
Nian Wang et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)
BRD4 blockage alleviates pathological cardiac hypertrophy through the suppression of fibrosis and inflammation via reducing ROS generation
Wen Zhu et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
STING is an essential regulator of heart inflammation and fibrosis in mice with pathological cardiac hypertrophy via endoplasmic reticulum (ER) stress
Yan Zhang et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
AntimiR-21 Prevents Myocardial Dysfunction in a Pig Model of Ischemia/Reperfusion Injury
Rabea Hinkel et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
Myocardial Interstitial Fibrosis in Nonischemic Heart Disease, Part 3/4
Javier Díez et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
Mitochondrial dysfunction in fibrotic diseases
Xinyu Li et al.
CELL DEATH DISCOVERY (2020)
Cardiac fibrosis: potential therapeutic targets
Shuin Park et al.
TRANSLATIONAL RESEARCH (2019)
Sacubitril/Valsartan Decreases Cardiac Fibrosis in Left Ventricle Pressure Overload by Restoring PKG Signaling in Cardiac Fibroblasts
Ryan M. Burke et al.
CIRCULATION-HEART FAILURE (2019)
The Interstitium in the Hypertrophied Heart
Brian P. Halliday et al.
JACC-CARDIOVASCULAR IMAGING (2019)
Dapagliflozin Attenuates Cardiac Remodeling in Mice Model of Cardiac Pressure Overload
Lin Shi et al.
AMERICAN JOURNAL OF HYPERTENSION (2019)
Reappraising myocardial fibrosis in severe aortic stenosis: an invasive and non-invasive study in 133 patients
Thomas A. Treibel et al.
EUROPEAN HEART JOURNAL (2018)
MicroRNA-221/222 Family Counteracts Myocardial Fibrosis in Pressure Overload-Induced Heart Failure
Robin Verjans et al.
HYPERTENSION (2018)
Left ventricular function in patients with hypertrophic cardiomyopathy and its relation to myocardial fibrosis and exercise tolerance
Dimitrios Maragiannis et al.
INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING (2018)
Platycodin D Reverses Pathological Cardiac Hypertrophy and Fibrosis in Spontaneously Hypertensive Rats
Yuan-Chuan Lin et al.
AMERICAN JOURNAL OF CHINESE MEDICINE (2018)
Myocardial Interstitial Fibrosis in Heart Failure Biological and Translational Perspectives
Arantxa Gonzalez et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
Mechanisms of physiological and pathological cardiac hypertrophy
Michinari Nakamura et al.
NATURE REVIEWS CARDIOLOGY (2018)
Myocardial fibrosis: biomedical research from bench to bedside
Mariann Gyoengyoesi et al.
EUROPEAN JOURNAL OF HEART FAILURE (2017)
Hypertension, left ventricular hypertrophy, and sudden cardiac death
Mohammad Shenasa et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2017)
Myocardial fibrosis predicts ventricular tachyarrhythmias
Marcello Disertori et al.
TRENDS IN CARDIOVASCULAR MEDICINE (2017)
A Clinical Perspective of Anti-Fibrotic Therapies for Cardiovascular Disease
Lu Fang et al.
FRONTIERS IN PHARMACOLOGY (2017)
The Processes and Mechanisms of Cardiac and Pulmonary Fibrosis
Lucy A. Murtha et al.
FRONTIERS IN PHYSIOLOGY (2017)
Effects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Proposal of a Novel Mechanism of Action
Milton Packer et al.
JAMA CARDIOLOGY (2017)
The Soft-and Hard-Heartedness of Cardiac Fibroblasts: Mechanotransduction Signaling Pathways in Fibrosis of the Heart
Kate M. Herum et al.
JOURNAL OF CLINICAL MEDICINE (2017)
Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2*and extracellular volume: A consensus statement by the Society for Cardiovascular Magnetic Resonance (SCMR) endorsed by the European Association for Cardiovascular Imaging (EACVI)
Daniel R. Messroghli et al.
JOURNAL OF CARDIOVASCULAR MAGNETIC RESONANCE (2017)
Personalizing Risk Stratification for Sudden Death in Dilated Cardiomyopathy The Past, Present, and Future
Brian P. Halliday et al.
CIRCULATION (2017)
Cardiac Fibrosis and Arrhythmogenesis
My-Nhan Nguyen et al.
COMPREHENSIVE PHYSIOLOGY (2017)
Sodium glucose transporter 2 (SGLT2) inhibition with empagliflozin improves cardiac diastolic function in a female rodent model of diabetes
Javad Habibi et al.
CARDIOVASCULAR DIABETOLOGY (2017)
Histological and Histometric Characterization of Myocardial Fibrosis in End-Stage Hypertrophic Cardiomyopathy: A Clinical-Pathological Study of 30 Explanted Hearts
Giuseppe Galati et al.
CIRCULATION-HEART FAILURE (2016)
Comprehensive characterisation of hypertensive heart disease left ventricular phenotypes
Jonathan C. L. Rodrigues et al.
HEART (2016)
Soluble guanylate cyclase stimulator riociguat and phosphodiesterase 5 inhibitor sildenafil ameliorate pulmonary hypertension due to left heart disease in mice
Kabita Pradhan et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2016)
Histologic validation of myocardial fibrosis measured by T1 mapping: a systematic review and meta-analysis
Kai-yue Diao et al.
JOURNAL OF CARDIOVASCULAR MAGNETIC RESONANCE (2016)
Myofibroblast secretome and its auto-/paracrine signaling
Ritin Bomb et al.
EXPERT REVIEW OF CARDIOVASCULAR THERAPY (2016)
Platycodin D Blocks Breast Cancer-Induced Bone Destruction by Inhibiting Osteoclastogenesis and the Growth of Breast Cancer Cells
Sun Kyoung Lee et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2015)
4-PBA prevents pressure overload-induced myocardial hypertrophy and interstitial fibrosis by attenuating endoplasmic reticulum stress
Tao Luo et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2015)
Attenuation of ER stress prevents post-infarction-induced cardiac rupture and remodeling by modulating both cardiac apoptosis and fibrosis
Tao Luo et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2015)
The liver X receptor agonist AZ876 protects against pathological cardiac hypertrophy and fibrosis without lipogenic side effects
Megan V. Cannon et al.
EUROPEAN JOURNAL OF HEART FAILURE (2015)
Targeted pharmacotherapy in progressive familial intrahepatic cholestasis type 2: Evidence for improvement of cholestasis with 4-phenylbutyrate
Emmanuel Gonzales et al.
HEPATOLOGY (2015)
Hepatology Snapshot: Mechanisms of liver fibrosis resolution
Frank Tacke et al.
JOURNAL OF HEPATOLOGY (2015)
Circulating Biomarkers of Myocardial Fibrosis The Need for a Reappraisal
Begona Lopez et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2015)
Coronary Microvascular Rarefaction and Myocardial Fibrosis in Heart Failure With Preserved Ejection Fraction
Selma F. Mohammed et al.
CIRCULATION (2015)
The pathogenesis of cardiac fibrosis
Ping Kong et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2014)
Fibrosis and heart failure
Ana Maria Segura et al.
HEART FAILURE REVIEWS (2014)
Association of Cardiotrophin-1 With Myocardial Fibrosis in Hypertensive Patients With Heart Failure
Begona Lopez et al.
HYPERTENSION (2014)
Enhanced resistance to permeability transition in interfibrillar cardiac mitochondria in dogs: effects of aging and long-term aldosterone infusion
Girma Asemu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2013)
Association of Fibrosis With Mortality and Sudden Cardiac Death in Patients With Nonischemic Dilated Cardiomyopathy
Ankur Gulati et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
Myofibroblast-mediated mechanisms of pathological remodelling of the heart
Karl T. Weber et al.
NATURE REVIEWS CARDIOLOGY (2013)
Therapeutic Cardiac-Targeted Delivery of miR-1 Reverses Pressure Overload-Induced Cardiac Hypertrophy and Attenuates Pathological Remodeling
Ioannis Karakikes et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2013)
Targeting Fibrosis for the Treatment of Heart Failure: A Role for Transforming Growth Factor-β
Amanda J. Edgley et al.
CARDIOVASCULAR THERAPEUTICS (2012)
Collagen Cross-Linking But Not Collagen Amount Associates With Elevated Filling Pressures in Hypertensive Patients With Stage C Heart Failure Potential Role of Lysyl Oxidase
Begona Lopez et al.
HYPERTENSION (2012)
MicroRNA-214 protects the mouse heart from ischemic injury by controlling Ca2+ overload and cell death
Arin B. Aurora et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Regional mechanics determine collagen fiber structure in healing myocardial infarcts
Gregory M. Fomovsky et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2012)
Place your BETs: the therapeutic potential of bromodomains
R. K. Prinjha et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2012)
A Primer on Arrhythmias in Patients with Hypertrophic Cardiomyopathy
Katy E. Bockstall et al.
CURRENT CARDIOLOGY REPORTS (2012)
Low dose of the liver X receptor agonist, AZ876, reduces atherosclerosis in APOE*3Leiden mice without affecting liver or plasma triglyceride levels
J. W. A. van der Hoorn et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
β-Myosin Heavy Chain Is Induced by Pressure Overload in a Minor Subpopulation of Smaller Mouse Cardiac Myocytes
Javier E. Lopez et al.
CIRCULATION RESEARCH (2011)
Fibrosis and Cardiac Arrhythmias
Sanne de Jong et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2011)
Mitochondrial Targeted Antioxidant Peptide Ameliorates Hypertensive Cardiomyopathy
Dao-Fu Dai et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2011)
The Collagen Family
Sylvie Ricard-Blum
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2011)
Single Oral Dose Toxicity Test of Platycodin D, a Saponin from Platycodin Radix in Mice
Won-Ho Lee et al.
TOXICOLOGICAL RESEARCH (2011)
The calcineurin-myocyte enhancer factor 2c pathway mediates cardiac hypertrophy induced by endoplasmic reticulum stress in neonatal rat cardiomyocytes
Zhen-Ying Zhang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2010)
Celecoxib, but not rofecoxib or naproxen, attenuates cardiac hypertrophy and fibrosis induced in vitro by angiotensin and aldosterone
Bing H. Wang et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2010)
Autophagy in transition from hypertrophic cardiomyopathy to heart failure
Anna Fidzianska et al.
JOURNAL OF ELECTRON MICROSCOPY (2010)
Molecular distinction between physiological and pathological cardiac hypertrophy: Experimental findings and therapeutic strategies
Bianca C. Bernardo et al.
PHARMACOLOGY & THERAPEUTICS (2010)
The Impact of Obesity on the Left Ventricle The Multi-Ethnic Study of Atherosclerosis (MESA)
Evrim B. Turkbey et al.
JACC-CARDIOVASCULAR IMAGING (2010)
The chromatin-targeting protein Brd2 is required for neural tube closure and embryogenesis
Aron Gyuris et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2009)
Impact of Treatment on Myocardial Lysyl Oxidase Expression and Collagen Cross-Linking in Patients With Heart Failure
Begona Lopez et al.
HYPERTENSION (2009)
MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts
Thomas Thum et al.
NATURE (2008)
Epac activation, altered calcium homeostasis and ventricular arrhythmogenesis in the murine heart
Sandeep S. Hothi et al.
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2008)
Signal integration in the endoplasmic reticulum unfolded protein response
David Ron et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)
SirT3 is a nuclear NAD+-dependent histone deacetylase that translocates to the mitochondria upon cellular stress
Michael B. Scher et al.
GENES & DEVELOPMENT (2007)
Fibrosis, not cell size, delineates β-myosin heavy chain reexpression during cardiac hypertrophy and normal aging in vivo
Kumar Pandya et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Eplerenone prevents adverse cardiac remodelling induced by pressure overload in atrial natriuretic peptide-null mice
Veronica Franco et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2006)
Intermittent pressure overload triggers hypertrophy-independent cardiac dysfunction and vascular rarefaction
Cinzia Perrino et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Role of reactive oxygen species in TGF-β1-induced mitogen-activated protein kinase activation and epithelial-mesenchymal transition in renal tubular epithelial cells
DY Rhyu et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
Activation delay after premature stimulation in chronically diseased human myocardium relates to the architecture of interstitial fibrosis
T Kawara et al.
CIRCULATION (2001)
Share Paper
